Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.

Keenan HA, Sun JK, Levine J, Doria A, Aiello LP, Eisenbarth G, Bonner-Weir S, King GL.

Diabetes. 2010 Nov;59(11):2846-53. doi: 10.2337/db10-0676. Epub 2010 Aug 10.

2.

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.

Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R.

Diabetologia. 1999 May;42(5):608-16.

PMID:
10333055
3.

Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.

Sugihara S, Sakamaki T, Konda S, Murata A, Wataki K, Kobayashi Y, Minamitani K, Miyamoto S, Sasaki N, Niimi H.

Diabetes. 1997 Nov;46(11):1893-7.

PMID:
9356042
4.

Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)--a 5-year follow-up of the Ehime study.

Murao S, Kondo S, Ohashi J, Fujii Y, Shimizu I, Fujiyama M, Ohno K, Takada Y, Nakai K, Yamane Y, Osawa H, Makino H.

Diabetes Res Clin Pract. 2008 Apr;80(1):114-21. doi: 10.1016/j.diabres.2008.01.024. Epub 2008 Mar 14.

PMID:
18342387
5.

Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).

Takeda H, Kawasaki E, Shimizu I, Konoue E, Fujiyama M, Murao S, Tanaka K, Mori K, Tarumi Y, Seto I, Fujii Y, Kato K, Kondo S, Takada Y, Kitsuki N, Kaino Y, Kida K, Hashimoto N, Yamane Y, Yamawaki T, Onuma H, Nishimiya T, Osawa H, Saito Y, Makino H; Ehime Study.

Diabetes Care. 2002 Jun;25(6):995-1001.

PMID:
12032105
6.

Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?

Tiberti C, Buzzetti R, Anastasi E, Dotta F, Vasta M, Petrone A, Cervoni M, Torresi P, Vecci E, Multari G, Di Mario U.

Diabetes Metab Res Rev. 2000 Jan-Feb;16(1):8-14.

PMID:
10707033
7.

Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.

Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, Yoshioka K, Kitagawa Y, Nakano K, Yoshikawa T, Nakamura N.

Immunol Lett. 2005 Jul 15;99(2):180-5. Epub 2005 Mar 17.

PMID:
16009268
8.

Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.

Rother KI, Spain LM, Wesley RA, Digon BJ 3rd, Baron A, Chen K, Nelson P, Dosch HM, Palmer JP, Brooks-Worrell B, Ring M, Harlan DM.

Diabetes Care. 2009 Dec;32(12):2251-7. doi: 10.2337/dc09-0773. Epub 2009 Oct 6.

10.

[Subclassification of seronegative type 1 diabetic subjects with HLA-DQ genotypes].

Zhang DM, Zhou ZG, Zhang C, Huang G, Jin P, Wang JP, Wei JL, Hu BY.

Zhonghua Nei Ke Za Zhi. 2004 Mar;43(3):174-8. Chinese.

PMID:
15059369
11.

HLA class II alleles susceptibility markers of type 1 diabetes fail to specify phenotypes of ketosis-prone diabetes in adult Tunisian patients.

Laadhar L, Harzallah F, Zitouni M, Kallel-Sellami M, Fekih M, Kaabachi N, Slimane H, Makni S.

Exp Diabetes Res. 2011;2011:964160. doi: 10.1155/2011/964160. Epub 2011 Mar 2.

12.
13.

Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.

Maioli M, Pes GM, Delitala G, Puddu L, Falorni A, Tolu F, Lampis R, Orrù V, Secchi G, Cicalò AM, Floris R, Madau GF, Pilosu RM, Whalen M, Cucca F.

Eur J Endocrinol. 2010 Oct;163(4):541-9. doi: 10.1530/EJE-10-0427. Epub 2010 Jul 5.

14.

[Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].

Pánczél P, Hosszúfalusi N, Bornemisza B, Horváth L, Jánoskuti L, Füst G, Rajczy K, Vatay A, Prohászka Z, Madácsy L, Luczay A, Blatniczky L, Halmos T, Körner A, Szilvási I, Romics L.

Orv Hetil. 2001 Nov 18;142(46):2571-8. Hungarian.

PMID:
11770176
15.

Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.

Jaeger C, Allendörfer J, Hatziagelaki E, Dyrberg T, Bergis KH, Federlin K, Bretzel RG.

Horm Metab Res. 1997 Oct;29(10):510-5.

PMID:
9405979
16.

[Use of ABC typing to redefine subtypes of acute-onset type 1 diabetes mellitus: study of 308 patients].

Zhang C, Zhou ZG, Lin J, Huang G, Wang JP, Zhang DM, Zhou M, Yang XL.

Zhonghua Yi Xue Za Zhi. 2008 Mar 25;88(12):797-801. Chinese.

PMID:
18756979
17.

Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.

Groop L, Miettinen A, Groop PH, Meri S, Koskimies S, Bottazzo GF.

Diabetes. 1988 Jan;37(1):99-103.

PMID:
3275559
18.

Type 1 diabetes and LADA--occurrence of HLA-DRB1 *03 and DRB1 *04 alleles in two age different groups of diabetics.

Weber P, Meluzínová H, Kubesová H, Ambrosová P, Polcarová V, Cejkova P, Cerna M.

Adv Gerontol. 2010;23(2):243-8.

PMID:
21033293
20.

Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype.

Petrone A, Galgani A, Spoletini M, Alemanno I, Di Cola S, Bassotti G, Picardi A, Manfrini S, Osborn J, Pozzilli P, Buzzetti R.

Diabetes Metab Res Rev. 2005 May-Jun;21(3):271-5.

PMID:
15786423
Items per page

Supplemental Content

Write to the Help Desk